Stockreport

Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination

Qualigen Therapeutics, Inc.  (QLGN) 
PDF CARLSBAD, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), announced today that on May 23, 2024, it re [Read more]